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Accurate quantification of 
homologous recombination in 
zebrafish: brca2 deficiency as a 
paradigm
Jeroen Vierstraete1,2, Andy Willaert1, Petra Vermassen1, Paul J. Coucke1, Anne Vral2 & 
Kathleen B. M. Claes  1
Homologous Recombination (HR) repair is essential for repairing DNA double strand breaks (DSB) in 
dividing cells and preventing tumorigenesis. BRCA2 plays an important role in HR by recruiting the 
DNA recombinase RAD51 to the DSB. Despite being a popular model organism in genetic and cancer 
research, knowledge on the conservation of the HR pathway and function of zebrafish Brca2 is limited. 
To evaluate this, we developed a Rad51 foci assay in zebrafish embryos. We identified the zebrafish 
embryonic intestinal tissue as an ideal target for Rad51 immunostaining. After inducing DSB through 
irradiation, Rad51 foci were present in irradiated embryos but not in unirradiated controls. We present 
a method for accurate quantification of HR. Both morpholino-induced knockdown and knockout of 
Brca2 lead to almost complete absence of Rad51 foci in irradiated embryos. These findings indicate 
conserved function of Brca2 in zebrafish. Interestingly, a statistically significant decrease in Rad51 foci 
was observed in Brca2 heterozygous carriers compared to wild types, indicative of haploinsufficiency, 
a hypothesised cause of some tumours in patients with a germline BRCA2 mutation. In conclusion, 
we demonstrated the suitability of zebrafish as an excellent in vivo model system for studying the HR 
pathway and its functionality.
In every cell, the genomic material is constantly being damaged by exogenous or endogenous mechanisms1. 
Double Strand Breaks (DSB) are especially pathogenic, as there is no complementary base template available 
for accurate repair. These DSB can be repaired through two pathways: Non-Homologous End Joining (NHEJ) 
and Homologous Recombination (HR)1,2. NHEJ ligates the DNA ends, but does so in an error-prone fashion3. 
Misrepair can lead to gross chromosomal translocations, amplifications of proto-oncogenes, or deletions of 
tumour suppressor genes, all of which can result in tumorigenesis and ultimately carcinogenesis1,4. HR uses the 
sister chromatid as a template to repair in an error-free fashion. Therefore, HR can only occur during the late S-/
G2-phase of the cell cycle, when the DNA has been duplicated prior to cell division3,5,6. Two key players in the 
HR pathway are BRCA1 and BRCA2, which play a crucial role in recruiting the DNA recombinase RAD51 to 
the vicinity of the DSB. Localisation of RAD51 to the site of the DSB is essential for strand invasion of the sister 
chromatid and can be visualised through a RAD51 foci immunostaining. Knockdown of BRCA1 or BRCA2 leads 
to loss of these RAD51 foci6,7. Germline mutations in BRCA1 or BRCA2 are associated with a highly increased 
risk for breast and ovarian cancer6.
Zebrafish (Danio Rerio) contains orthologues for many genes involved in DNA repair pathways that are avail-
able in higher eukaryotes, including the brca2 gene8–10. Despite its poor overall homology with human BRCA2 
(22%), the functional N-terminal transcription activation domain, C-terminal DNA binding domain and RAD51 
binding BRCA repeats are conserved in the zebrafish Brca2 protein9,10. It was shown that zebrafish brca2 acts as 
a caretaker gene and is involved in maintaining genomic integrity through HR9,10. Brca2 deficient zebrafish mod-
els were shown to be sensitive to mitomycin C (MMC), a DNA crosslinker for which repair through HR is essen-
tial, and develop an all-male phenotype due to failure of meiotic recombination during the sex determination 
period9,10. Human BRCA2−/− patients develop Fanconi Anaemia, which is characterised by genomic instability 
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and sensitivity to MMC11. Liu et al. provided evidence that zebrafish Rad51 is essential for HR in zebrafish, as 
morpholino mediated knockdown of this protein resulted in decreased HR12.
So far, up to 20 Fanconi Anaemia (FA) genes have been identified (FANCA, B, C, D1 (BRCA2), D2, E, F, G 
(XRCC9), I, J (BRIP1), L, M, N (PALB2), O (RAD51C), P (SLX4), Q (ERRC4), R (RAD51), S (BRCA1), T (UBE2T) 
and U (XRCC2))13. With the notable exception of BRCA1, zebrafish has the complete set of FA genes at its dis-
posal14. The apparent absence of zebrafish brca1, a gene with a plethora of important functions, suggests that some 
modifications between the human and zebrafish HR repair pathway have occurred during evolution14,15.
Despite the importance of HR in maintaining genomic stability, not much is known about this pathway in 
zebrafish8. As zebrafish is an increasingly important model organism for studying cancer (pathway discovery, 
compound screening, drug discovery, …) it is crucial to unravel how this repair pathway functions in zebraf-
ish16,17. Therefore, we developed the Rad51 foci assay in zebrafish, enabling the accurate measurements of in vivo 
HR activity under a wide range of experimental conditions.
Results
Determination of proliferative tissues in 72 hpf zebrafish embryos. As HR can only occur in divid-
ing cells, it is essential to target a tissue that has high proliferative capabilities. Sagittal and transversal sections of 
72 hours post fertilisation (hpf) wild type embryos were made and stained for Proliferating Cell Nuclear Antigen 
(PCNA), which stains cells in G1-, S-, G2- and M-phase of the cell cycle and acts as a general marker for dividing 
cells. PCNA is most noticeable in the tectum and throughout the intestinal tract (Fig. 1a,b). All nuclei in the 
intestinal tract show strong PCNA staining, which indicates the high proliferative capacity of these cells at 72 hpf. 
Due to the prominent staining and large morphology of the nuclei, we focused on the intestinal tract for further 
stainings.
To further confirm the proliferative capacity of the intestinal tract, embryos were administered 
Bromodeoxyuridine (BrdU) at 72 hpf for 2 hours and subsequently fixed and stained with an anti-BrdU antibody. 
BrdU is an analogue of thymine and will be incorporated into the DNA of cells during the S-phase. Transversal 
sections reveal that throughout the gastro-intestinal tract, cells incorporate BrdU (Fig. 1c). Quantification of the 
number of BrdU + cells show that up to 40% of the intestinal epithelial cells have incorporated BrdU, indicating 
that these cells are actively going through S-phase.
In a third experiment, we examined the intestinal tract of 72 hpf transgenic Tg(EF1a: mCherry-zGem)oki011 
zebrafish, which expresses an mCherry-fused 100-amino acid peptide of geminin under the control of the 
EF1α promotor and allows for fluorescent visualisation of the nuclei of cells that are in late S-/G2-phase of the 
cell cycle18,19. Since the mCherry signal is destroyed during the fixation process, an immunostaining with an 
anti-mCherry antibody was performed. Geminin positive cells were clearly visible in and around the intestinal 
tract (Fig. 1d–f). Quantification of intestinal cells in three embryos shows that on average 40–60% of the nuclei in 
the intestinal tract were positive for geminin.
The three different markers (PCNA; BrdU; geminin), therefore, manifest the proliferative nature of the intes-
tinal tissue in zebrafish embryos. Moreover, a large proportion of the cells in the intestinal tract are in late S-/
G2-phase of the cell cycle, which are the phases where HR is active. As such, this tissue was chosen for optimisa-
tion of the Rad51 foci assay.
Wild type embryos show Rad51 foci upon irradiation. To optimise conditions for visualisation of 
Rad51 foci, a time kinetics experiment was performed. Embryos at 72 hpf were irradiated with 10 or 20 Gy and 
fixed at 1, 3, 5, 7 and 9 hours post irradiation (hpi). Unirradiated controls at 5 and 9 hours were also included. 
Transversal sections of the intestinal tract were made. To show that irradiation with 10 and 20 Gy induces DSB, 
immunostaining for γH2AX, a DSB marker, was conducted. An abundance of nuclear γH2AX foci was detected 
in irradiated embryos, but not in unirradiated controls (Supplementary Fig. S1). Staining for Rad51 showed for-
mation of Rad51 foci in irradiated embryos while unirradiated controls contain almost no Rad51 foci (Fig. 2a,b).
Considering all intestinal cells to determine the mean number of foci/cell would result in an underestimation 
of Rad51 foci, as geminin staining showed that a substantial proportion (~40–60%) of these cells are not in late 
S-/G2-phase. Instead the following method was developed: as the embryos were irradiated with high doses, all 
cells have DSB (as observed with the γH2AX foci assay). Thus, we hypothesise that all cells that were in late S- or 
G2-phase at the moment of irradiation should show Rad51 foci and we restricted the quantification to cells con-
taining foci.
=Mean foci per cell in irradiated embryos Total number of foci
#cells containing foci (1)
This approach cannot be followed for unirradiated embryos (no DSB induced). Instead, we took the total 
number of foci and divided it by the expected number of cells that are capable of HR in these controls. This num-
ber was calculated by multiplying the percentage of Rad51 positive cells from irradiated conditions in the same 
experiment (typically 40–60%) with the total number of intestinal cells in the controls.
=
∗
Mean foci per cell in controls Total number of foci
%expected HR capable cells total amount of cells (2)
For convenience purposes, the values obtained in irradiated and unirradiated embryos will always be referred 
to as ‘foci/cell’. A visual representation of this quantification approach can be found in Fig. 2c. All irradiated 
embryos display distinct nuclear foci in intestinal cells while controls are almost completely devoid of Rad51 
foci (Fig. 3; Supplementary Table S5). Two-way ANOVA did not indicate a difference in foci/cell between the 
different time points. However, the foci observed at 1 hour were more subtle, hampering adequate quantification, 
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compared to later time points. This indicates that 1 hpi, Rad51 is still being recruited to the site of the DSB. For all 
subsequent experiments, embryos of 72 hpf were irradiated with 20 Gy, fixated at 5 hpi and sectioned.
Of note, in cells of the tectum and the retina, other highly proliferative regions of the zebrafish embryos 72 
hpf, Rad51 foci are also visible. However, visualisation and adequate quantification of the number of Rad51 foci 
in these regions is challenging due to the smaller size of the cells, the close proximity of the cells to one another 
and the difficulty for sectioning the correct region.
The quantification method used in the time kinetics experiment was based on the assumption that all cells in 
late S-/G2-phase repair a number of DSB by means of HR and thus show Rad51 foci after irradiation. To confirm 
that this quantification is reliable, three transgenic Tg(EF1a: mCherry-zGem)oki011 embryos were irradiated with 
20 Gy, fixed at 5 hpi and stained for both Rad51 and mCherry (zGem) (Fig. 4). Unirradiated embryos were also 
included.
Figure 1. Stainings for PCNA (a,b), BrdU (c) and geminin (d-f). All stainings were performed on 72 hpf 
embryos. (a) Sagittal section stained for PCNA. Strong staining is found in the tectum (blue arrow) and gastro-
intestinal tract (black arrows). (b) Transversal section stained for PCNA. PCNA stains positive in the gut tube, 
swim bladder and liver. (c) Transversal section stained for BrdU. BrdU intake is prominent in intestinal cells. 
(d–f) Separate images of nuclear staining (DAPI) (d), mCherry (zGem signal) (e) and overlay (f). (f) mCherry 
signal is present in a large proportion of intestinal cells.
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Figure 2. Representative images of Rad51 staining. Rad51 foci are absent in unirradiated sample (a), while 
irradiated sample displays clear Rad51 foci (b) (green fluorescence). (c) Schematic drawing of an unirradiated 
(left) and irradiated (right) gut tube section. Cells in blue are in late S-/G2-phase and thus capable of HR. Cells 
in white are not capable of HR and will never show Rad51 foci. Red dots indicate Rad51 foci. Quantifying all 
cells would lead to a serious underestimation of your signal, due to the large proportion of non-HR capable 
cells. Instead, quantifying only cells containing foci will give a more true value for irradiated conditions. To 
estimate the amount of HR capable cells in unirradiated samples, one can extrapolate the percentage of cells that 
contain Rad51 foci from the irradiated samples.
Figure 3. Time kinetics experiment. Graph displaying the number of foci/cell in function of different time 
points. Three embryos per condition were irradiated with 10 or 20 Gy and fixed at different time points, ranging 
from 1–9 hours. Unirradiated embryos were also fixed at 5 and 9 hours. Error bars display 95% CI.
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Quantification was conducted in two ways. First, all cells containing foci were included (disregarding if cells 
stained positive for geminin or not) and the mean number of foci/cell was calculated using formulas (1) and (2). 
In Supplementary Fig. S2 and Supplementary Table S6 these “hypothesised values” are shown. Second, only the 
geminin positive cells were included and the number of foci divided by the amount of geminin positive cells was 
calculated. These data are indicated in Supplementary Fig. S2 and Supplementary Table S6 as“true values”. For 
both the irradiated and unirradiated embryos, the “hypothesised value” correlates very well with the “true value” 
(Irradiated: 6.14 versus 6.06 foci/cell respectively; unirradiated: 0.67 vs 0.47 foci/cell respectively, Supplementary 
Table S6), confirming the validity of our quantification method.
Knockout/knockdown of Brca2 results in absence of Rad51 foci. A brca2 zebrafish knockdown 
model was obtained by injecting 1-cell stage wild type embryos with a splice-blocking morpholino targeting the 
exon7/intron7 splice site of brca2. At 72 hpf, embryos were irradiated with 20 Gy, followed by fixation at 5 hpi. 
Three uninjected embryos (MO−) were also irradiated. RT-PCR was performed to check the functionality of 
the morpholino. Control embryos show normal amplification of a region between exon 4 and exon 8 (250 bp). 
Injection of the morpholino causes a band shift to about 1600 bp, corresponding to an intron 7 retention (Fig. 5a), 
and multiple stop codons are predicted within the first 50 bp by this intron retention.
In morphants, a severe loss of the number of Rad51 foci/cell was noticed when compared to controls (6.3 
versus 0.2 foci/cell; p = 10−4) (Fig. 5b). To confirm that DSB were induced in both groups, the γH2AX foci assay 
was performed. Both wild types and morphants show an abundance of γH2AX foci compared to unirradiated 
embryos (Fig. 5c).
In addition to the brca2 MO-mediated knockdown model, three different knockout lines for brca2 were tested 
with the Rad51 foci assay: brca2sa22682, brc2hg5 and brca2cmg35 (in-house developed). As brca2−/− fish develop to 
infertile males, most likely due to apoptosis of oocytes during the critical period of sex determination of zebrafish, 
these homozygotes cannot be used for propagation9,10. This ‘all-male’ phenotype was confirmed in our in-house 
developed brca2cmg35 line, where 16 adult brca2−/− fish developed exclusively as males (chi², p = 6.10−5). In addi-
tion, using offspring from brca2−/− fish is discouraged as these fish would have a dysfunctional HR pathway 
and may present with genomic instability. This predisposition could be transmitted to their offspring and affect 
results. Therefore, in this experiment, heterozygous carriers of each knock-out line were in-crossed and resulting 
embryos were irradiated with 20 Gy and fixed at 5 hpi. At least three embryos per condition were quantified. For 
all lines, Rad51 foci were present in both brca2+/+ and brca2+/− embryos, whilst being absent in brca2−/− embryos 
(Fig. 6; Supplementary Table S7). Interestingly, a statistically significant difference was also observed between 
brca2+/+ and brca2+/− in the brca2cmg35+/− line, with less foci being present in the brca2+/− condition (p = 0.02). 
The two other lines showed a similar trend but results were not significant. When combining the data from all 
three lines, the difference between brca2+/+ and brca2+/− was statistically significant (p = 0.02).
Discussion
Zebrafish is an increasingly popular model system in genetic and cancer research because of its relative small size, 
ease of housing, ex utero development and initial transparency. However, current knowledge on the HR repair 
pathway of this model organism is limited8,20.
In this work, we aimed to develop an assay to accurately quantify HR activity in zebrafish through means of 
Rad51 foci quantification. Furthermore, using this method, we wanted to determine if zebrafish Brca2 conserved 
its function in recruitment of Rad51 to the site of DSB.
To be able to study HR in zebrafish embryos, we first needed to identify a suitable tissue showing high HR 
activity. Through PCNA staining, we identified that intestinal cells 72 hpf are particularly highly proliferative. This 
confirms previous findings where it has been reported that between 26 hpf and 72 hpf the entire intestinal endo-
derm shows high proliferative capacity21,22. BrdU stainings performed on 72 hpf embryos indicated that about 
40% of cells in the intestinal tract are in S-phase. In contrast, Wallace et al. found about 20% S-phase in intestinal 
cells in 72 hpf embryos. This might be attributed by differences between protocols, as they performed a 1 hour 
Figure 4. Rad51/geminin co-staining of irradiated embryo. Rad51 foci (green) are almost exclusively found in 
geminin positive nuclei (red).
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incubation while we applied 2 hours23. Finally, geminin stainings determined that about 40–60% of intestinal 
cells are in late S-/G2-phase at 72 hpf. The high number of cells in late S-/G2-phase makes intestinal tissue highly 
interesting for studies on HR because during these phases sufficient genetic material has been duplicated allow-
ing the cell to repair DSB through HR24. Another advantage of intestinal tissue is the large size of the cells and 
their nuclei. This allows for adequate visualisation of discrete nuclei as well as Rad51 foci in these nuclei. Finally, 
the gut tube spans a large part of the embryo allowing the sectioning of intestinal cells to be straightforward. In 
conclusion, zebrafish embryonic intestinal tissue is an ideal target tissue when assessing HR functionality in this 
organism.
To activate the HR pathway, DSB were induced through ionising irradiation. A time kinetics experiment was 
performed, where 10 and 20 Gy were administered to 72 hpf embryos. A dose of 20 Gy and assessment of HR 
activity at 5 hpi was identified as optimal. Also, other studies reporting on radiation experiments in zebrafish, 
such as screening of radiation modifiers25 and engraftment experiments26, use up to 20 Gy. Studies where the 
Figure 5. Results of morpholino experiment. (a) Digital gel of RT-PCR (obtained by Labchip®GX software) 
of uninjected (MO−) and injected (MO+) embryos. Injecting the morpholino results in retention of intron 7, 
resulting in a transcript containing a premature stop codon. This is visualised as a longer RT-PCR fragment, 
using primers located in exon 4 and 8 (expected size: 250 bp; in case of intron 7 retention: 1600 bp). In the 
morphants, there is a clear band of 1600bp, indicative for intron retention. (b) Quantification of Rad51 foci in 
three morphants (MO+) and uninjected (MO−) embryos. Almost no Rad51 foci are present in the morphants. 
Error bars display 95% CI. (c) γH2AX foci are present in both irradiated wild types (upper left) and morphants 
(lower left). Wild types display clear Rad51 foci (upper right), while morphants display no Rad51 foci.
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RAD51 foci assay has been performed in human tumour biopsies and mammalian cell lines also use rather high 
doses (ranging from 5–12 Gy)7,27,28. Although a majority of the DSB are repaired through NHEJ, a sub-fraction of 
radiation-induced DSB are specifically repaired by HR. This is due to the complexity of the DSB repair resulting 
from increasing doses29,30. The Rad51 foci assay, therefore, requires high doses.
HR activity was quantified as the mean number of Rad51 foci/cell as described in the results section. This 
quantification was validated using the transgenic line Tg(EF1a: mCherry-zGem)oki011. Geminin is known to 
be active in the late S-/G2-phase and was previously shown to be an excellent HR marker in combination with 
RAD51 staining in human tumour tissues7,31. Of note, at any given dose and time point γH2AX foci are more 
prominent than Rad51 foci. This suggests that besides HR, other DSB repair pathways are also active. Liu et al. 
previously showed that NHEJ is the most dominant DSB repair pathway in zebrafish embryos12.
After optimizing the zebrafish Rad51 foci assay on wild type embryos, we determined if deficiency of Brca2 
leads to absence of Rad51 foci recruitment to the DSB. Using a brca2 MO-mediated knockdown, a complete 
loss of Rad51 foci was observed. However, as morpholinos may produce off-targeted effects32, we validated our 
results in three stable brca2 mutant lines, harbouring different inactivating mutations in exon 8 (brca2cmg35) or 
11 (brca2sa22682, brca2hg5). For all stable lines, Rad51 foci were absent in mutants, while being present in both wild 
types and heterozygous carriers. We conclude that Brca2 has conserved its main function in recruiting Rad51 
and that our assay can accurately quantify HR functionality. Morpholinos have the advantage that every injected 
embryo is deficient for Brca2, while only 25% of offspring from heterozygous carriers will be mutant. This makes 
the use of stable lines more labour intensive. However, morpholino-mediated knockdown is only temporary. The 
choice should be made in function of the data and experiments required.
Interestingly, for the brca2cmg35 line we observed a borderline statistically significant difference in the number 
of Rad51 foci/cell between brca2+/+ and brca2+/− embryos. This suggests that HR is less efficient in brca2+/− 
cells compared to brca2+/+ cells. In general, tumours from patients with a germline BRCA2 mutation contain 
an inactivating mutation of the second allele. However, in a considerable number of human BRCA1/2 associ-
ated breast tumours, loss of heterozygosity (LOH) of the wild type allele is not observed33–35. It has been sug-
gested that BRCA1/2 haploinsufficiency may cause genomic instability, initiating tumorigenesis6,33,35. Recently, 
a study on 160 BRCA1 and BRCA2 germline mutation-associated breast and ovarian cancer found absence of 
LOH in a subset of patients, in which they postulate haploinsufficiency as a possible mechanism for some of these 
cases36. Our data obtained in the zebrafish brca2+/− embryos indeed support reduced repair capacity through 
HR. The observed difference, however, is small (13% reduction). Nevertheless, a small reduction in HR could 
Figure 6. Rad51 foci quantification of brca2sa22682/+, brca2hg5/+ and brca2cmg35/+ in-cross. At least three embryos 
per genotype were stained. All brca2−/− lines show a complete absence of Rad51 foci. brca2+/+ embryos display 
more Rad51 foci than brca2+/−. This difference is statistically significant in brca2cmg35 or when combining data 
from all lines. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
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hypothetically lead to additional accumulation of mutations and eventually tumorigenesis in some cases. More 
studies are warranted to evaluate if the observed difference has an impact on repair capacity and how this can be 
translated to a tumorigenic process.
In conclusion, we have identified zebrafish embryonic intestinal cells as an ideal target to study the function-
ality of the HR pathway due to their highly proliferative activity and good morphology. Our study shows that 
zebrafish Brca2, like human BRCA2, plays a role in HR through recruitment of Rad51; furthermore, disabling 
Brca2 results in absence of Rad51 foci after irradiation. These results were observed in both morpholino injected 
embryos and in mutant zebrafish lines. We demonstrate here that zebrafish is a suitable model organism for 
studying HR functionality. Interestingly, the outcome of our experiments also suggests less efficient HR capacity 
in brca2+/− embryos. Further studies are warranted to evaluate if this leads to increased genomic instability due 
to haploinsufficiency.
We are convinced that, in the future, our Rad51 foci assay can be applied in combination with rescue experi-
ments to study the pathogenic effect of BRCA2 variants of unknown clinical significance37. Related to this, PARP 
inhibitors are a novel type of drug to selectively target HR deficient tumours through synthetic lethality38; our 
assay may be useful for testing the efficiency of new inhibitors. Another application may be related to evaluate the 
efficiency of Crispr-Cas9 mediated genome editing through HR in zebrafish.
Material and Methods
Zebrafish maintenance and lines. Zebrafish lines were housed in a Zebtec semi-closed recirculation 
housing system at a constant temperature (27–28 °C), pH (~7.5), conductivity (~550 µS) and light/day cycle 
(14/10). Fish were fed twice a day with dry food (Gemma Micro, Skretting) and once with artemia (Ocean 
Nutrition). The mutant brca2sa22682 line was purchased from the European Zebrafish Resource Center (EZRC, 
Karlsruhe institute, Germany); brca2cmg35 was generated using Crispr-Cas9 mutagenesis (cfr below); brca2hg5 was 
a kind gift from Dr. Heather Shive (North Carolina State University)9; Tg(EF1a: mCherry-zGem)oki011 was a kind 
gift from Dr. Ichiro Masai (Okinawa Institute of Science and Technology)18.
Ethic statement. This study was approved by the local animal ethics committee (Ghent University hospital, 
Ghent, Belgium) application numbers: ECD 14/70 and 16/67 K. All methods were carried out in accordance with 
the approved guidelines.
Crispr-Cas9 mutagenesis. Three sgRNA sequences targeting brca2 were designed using CRISPRdirect39. 
From these sequences, synthetic dsDNA consisting of a 5′ random sequence, T7 promotor, target-specific 
sequence (minus PAM) and a constant region were designed according to Boel et al.40. These dsDNA sequences 
were ordered as G-blocks at Integrated DNA Technologies (IDT). G-blocks were dissolved in 20 µl nuclease-free 
water. PCR conditions can be found in Supplementary data (Supplementary Table 2–4).
PCR product was purified with the Qiaquick PCR purification kit (Qiagen) following general guidelines of 
the manufacturer. In vitro transcription was performed using the MEGAshortscript™ Kit (Thermo Fisher). The 
MEGAclear™ Kit (Thermo Fisher) was used to purify the transcription reaction. RNA quality was verified on 
the Experion (Bio-Rad). 25 pg sgRNA was co-injected with 250 pg Cas9 protein (Cas9 wild type nuclease protein 
with NLS, ToolGen) during the 1-cell stage. Phenol red 6% was used to visualise injection. At 24 hpf, 10 embryos 
were harvested for DNA extraction, using the KAPA Express Extract DNA Extraction kit. PCR was performed 
according to manufacturer’s protocol using primers flanking the crispr region. Samples were deep sequenced on 
the MiSeq and somatic indel frequency was analysed using BATCH-GE40. If a high out-of-frame indel percentage 
was identified, mosaic fish (F0) were grown to adulthood. These were out-crossed and offspring (F1) was tested 
for the presence of the mutation. If present, offspring was grown to adulthood and genotyped for the mutation.
Morpholino injection. To knockdown zebrafish Brca2, a splice-blocking morpholino oligonucleotide (MO; 
Genetools) was designed targeting the exon7/intron7 boundary (5′-ATTGCgtatgtatgaatggtcttgc-3′) of brca2. At 
the 1-cell stage, wild type embryos were injected with 10 ng of the morpholino. The morpholino was dissolved in 
a 2% Phenol red solution for visualisation of injection.
RNA extraction and RT-PCR. Ten embryos per condition were dechorionated and rinsed with PBS. 175 µl 
TRIZOL (Invitrogen) was added and embryos were homogenised. After 5 min incubation 70 µl of chloroform was 
added and samples were centrifuged for 15 minutes at 11000 rpm at 4 °C. The upper phase was transferred to a 
new tube and 100% ethanol was added. This mixture was brought onto a RNeasy mini-spin column (Qiagen) and 
centrifuged at 9600 rcf for 30 seconds. Samples were treated with 350 µl RW1 and briefly centrifuged. 35 µl RDD 
buffer and 5 µl DNaseI were added on each column and after 15 min incubation 350 µl RW1 was added, followed 
by a brief centrifugation. Samples were subsequently treated twice with 500 µl RPE buffer after which the RNA 
was finally eluted in 30 µl RNAse free water. cDNA synthesis was performed using the IScript™ cDNA Synthesis 
Kit (Bio-Rad). Samples underwent RT-PCR with primers surrounding the target area of the morpholino (F: 
5′-CCTTGTTTGTTTGGCTCAGC-3′; R: 5′-CAGATGCAACCCGGTCC-3′). Sample sizing was conducted on 
the Labchip® GX capillary electrophoresis system.
BrdU labelling. At 72 hpf, embryos were treated with 10 mM BrdU (Sigma-Aldrich) in E3 medium for 
2 hours. BrdU was washed away prior to fixation.
Irradiation and fixation. At 72 hpf, embryos were irradiated with the Small Animal Radiation Research 
Platform (SARRP, Infinity Lab, Ghent University). Embryos underwent irradiation with doses of 10 or 20 Gy 
X-rays (220 kV, dose rate 2.77 Gy.min−1). Embryos were euthanised and fixed for 1 hour in 4% PFA after different 
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time points post irradiation (hpi) ranging between 1–9 hpi. Following fixation, embryos were placed in increasing 
alcohol concentrations and embedded in paraffin.
Immunostainings. Paraffin embedded embryos were sectioned in 5 µm sections and placed on slides. The 
embryos were then deparaffinised and underwent 20 minutes of steam antigen retrieval in citric buffer (pH 
6.1). For immunohistochemical stainings, slides were treated with 10% H2O2. Blocking serum was added to the 
samples to prevent aspecific binding. Slides were incubated with mouse anti-BrdU (1/100; Dako; M0744) or 
mouse anti-PCNA (1/100; Novo Castra; NCL-PCNA) for 2 hours. This was followed by incubation with biotiny-
lated RAM (1/200, Dako) and Strep-HRP (1/200, Dako) antibodies for 30 minutes and 3,3′-diaminobenzidine 
tetrahydrochloride (DAB, Sigma-Aldrich) exposure for 10 minutes. Slides were counterstained with Mayer’s 
Haematoxylin (Merck).
For immunofluorescent stainings, slides were treated with anti-γH2AX (1/1000; Bethyl Laboratories; IHC-
00059), anti-RAD51 (1/2000; Santa-Cruz, H-92) or anti-mCherry (Abcam; ab125096; 1C51) antibodies over-
night at 4 °C. Slides were then incubated with Goat-anti-Rabbit Dylight 488 antibody (1/1000, Sigma-Aldrich) 
or Goat-anti-Mouse Dylight 594 (1/1000 Sigma-Aldrich). Finally slides were treated with DAPI + fluoromount 
(Sigma-Aldrich). For PCNA staining, no antigen retrieval or counterstaining was performed. Unless mentioned 
otherwise, three embryos per condition were used.
Visualisation. Slides were scanned on a Zeiss Axio Observer.Z1 inverted microscope, using the Zen pro 
2012 software. γH2AX, Rad51 and geminin images were captured using fluorescent microscopy. To allow for foci 
analysis (γH2AX, Rad51), a 100x enlargement was used and Z-stacks were made (0.22 µm thickness). Images 
were deconvoluted (fast iterative) and an orthogonal projection of 10 slices was performed. For the quantification 
of %BrdU positive cells, 236 intestinal cells were counted. For the quantification of %geminin positive cells, 1024 
intestinal cells were counted. Quantification of Rad51 foci is explained in the results section.
Genotyping. During sectioning of paraffin embedded embryos, some sections were reserved for genotyping. 
DNA was extracted with the Kapa Express Extract kit (Kapa Biosystems) and PCR according to the manufac-
turer’s protocol was performed. Inactivating mutations and primers used for genotyping brca2hg5, brca2sa22682 
and brca2cmg35 can be found in Supplementary Table S1. PCR products were Sanger sequenced to determine the 
genotype.
Statistical analysis. Data was analysed using SPSS statistics 24 (IBM). Unless mentioned otherwise, groups 
were compared using the student’s t-test (two-sided, α = 0.05). Levene’s test for equality of variances was per-
formed. Graphs were made with Sigmaplot (Systat Software Inc.).
Data availability. All data generated or analysed during this study are included in this published article (and 
its Supplementary Information files).
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